52w high/low | ₹404.9 / ₹260 |
P/E ratio | 26.32 |
Dividend | 0 |
ROE | 13.8 |
ROCE | 18.11 |
Face value | 1 |
Book value | ₹140.44Cr |
Market capital | ₹8,305.76Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). FDC's formulation department designs and develops products for various global markets and the highly regulated markets of US and Europe. The company has built a visible presence in the Regulated and Emerging markets. Promoted as a partnership firm in 1936 by the late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods Fairdeal Corporation (P) Ltd, as the company was known, was converted into a private limited company in September 23rd, 1940. It set up a formulation unit at Jogeshwari, Bombay in 1949. FDC has 2 wholly owned subsidiaries namely FDC Inc. , USA and FDC International Ltd, UK and 1 Joint Venture business, namely Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. at South Africa as on 31 March 2019.